BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34122009)

  • 1. Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13.
    Falvella ACB; Smith BJ; Silva-Costa LC; Valença AGF; Crunfli F; Zuardi AW; Hallak JE; Crippa JA; de Almeida V; Martins-de-Souza D
    Front Mol Neurosci; 2021; 14():673144. PubMed ID: 34122009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13.
    Falvella ACB; Smith BJ; Silva-Costa LC; Valença AGF; Crunfli F; Zuardi AW; Hallak JE; Crippa JA; de Almeida V; Martins-de-Souza D
    Front Mol Neurosci; 2021; 14():814907. PubMed ID: 34924956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics.
    Xu H; Yang HJ; McConomy B; Browning R; Li XM
    Front Behav Neurosci; 2010; 4():8. PubMed ID: 20305752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia.
    Seabra G; de Almeida V; Reis-de-Oliveira G; Crunfli F; Antunes ASLM; Martins-de-Souza D
    Sci Rep; 2020 Jul; 10(1):12655. PubMed ID: 32724114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical Pathways Triggered by Antipsychotics in Human [corrected] Oligodendrocytes: Potential of Discovering New Treatment Targets.
    Brandão-Teles C; de Almeida V; Cassoli JS; Martins-de-Souza D
    Front Pharmacol; 2019; 10():186. PubMed ID: 30890939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
    Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
    Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone.
    Xu H; Yang HJ; Li XM
    Eur Arch Psychiatry Clin Neurosci; 2014 Mar; 264(2):121-9. PubMed ID: 23728937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination.
    Zhang Y; Zhang H; Wang L; Jiang W; Xu H; Xiao L; Bi X; Wang J; Zhu S; Zhang R; He J; Tan Q; Zhang D; Kong J; Li XM
    Schizophr Res; 2012 Jun; 138(1):8-17. PubMed ID: 22555017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies.
    Porter JH; Prus AJ
    Psychopharmacology (Berl); 2009 Apr; 203(2):279-94. PubMed ID: 18795269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nuclear distribution element genes in the typical and atypical antipsychotics effects on nematode Caenorhabditis elegans: Putative animal model for studying the pathways correlated to schizophrenia.
    Monte GG; Nani JV; de Almeida Campos MR; Dal Mas C; Marins LAN; Martins LG; Tasic L; Mori MA; Hayashi MAF
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():19-30. PubMed ID: 30578843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes.
    Steiner J; Martins-de-Souza D; Schiltz K; Sarnyai Z; Westphal S; Isermann B; Dobrowolny H; Turck CW; Bogerts B; Bernstein HG; Horvath TL; Schild L; Keilhoff G
    Front Cell Neurosci; 2014; 8():384. PubMed ID: 25477781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice.
    Sonego AB; Gomes FV; Del Bel EA; Guimaraes FS
    Behav Brain Res; 2016 Aug; 309():22-8. PubMed ID: 27131780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia.
    Gururajan A; Taylor DA; Malone DT
    Behav Brain Res; 2011 Sep; 222(2):299-308. PubMed ID: 21458498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice.
    Moreira FA; Guimarães FS
    Eur J Pharmacol; 2005 Apr; 512(2-3):199-205. PubMed ID: 15840405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of Human HOG and MO3.13 Cell Lines as a Model to Study Oligodendrocyte Functioning.
    De Kleijn KMA; Zuure WA; Peijnenborg J; Heuvelmans JM; Martens GJM
    Cells; 2019 Sep; 8(9):. PubMed ID: 31533280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone.
    Zhang H; Zhang Y; Xu H; Wang L; Adilijiang A; Wang J; Hartle K; Zhang Z; Zhang D; Tan Q; Kong J; Huang Q; Li XM
    Psychiatry Res; 2014 May; 216(3):438-45. PubMed ID: 24613202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors.
    Rodrigues da Silva N; Gomes FV; Sonego AB; Silva NRD; Guimarães FS
    Pharmacol Res; 2020 Jun; 156():104749. PubMed ID: 32151683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol.
    Gomes FV; Llorente R; Del Bel EA; Viveros MP; López-Gallardo M; Guimarães FS
    Schizophr Res; 2015 May; 164(1-3):155-63. PubMed ID: 25680767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
    Zuardi AW; Crippa JA; Hallak JE; Moreira FA; Guimarães FS
    Braz J Med Biol Res; 2006 Apr; 39(4):421-9. PubMed ID: 16612464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.